Generation of custom value frameworks tailored to demonstrate the full value of your assets.
The future of
To achieve a truly value-based system...
it is vital to encapsulate all the attributes of value that a new product brings into a single value framework. Being prepared for the wider use of value frameworks is essential to ensure the future success of your assets.
Inbeeos’ i-vbp® is a tool that enables the generation of custom value frameworks...
tailored to demonstrate the full value of your assets. We work with you to identify your assets key value drivers, quantify their benefit and distil these into intuitive value metrics and associated value-based prices.
i-vbp® puts the power of Multi- Criteria Decision Analysis (MCDA) value frameworks in your hands...
We work with you from the very beginning to define the right framework for your needs. Value frameworks are completely transparent and can be dynamically modified to reflect different locations and stakeholder perspectives so that results are easy to communicate.
Support your market access discussions and decisions with quantitative value data.
Connect your product and market access teams with pricing and probability of market access success metrics.
Always stay relevant to patients by ensuring you consider what they value most.
How does i-vbp® work?
There are always numerous areas where a product can demonstrate value beyond pure efficacy and safety. Consider the impact an asset has on a patients Quality of Life, the burden of disease within the therapy area or even a patient’s preference for an oral tablet over an intravenous injection. All these aspects can contribute to realising the full value of a health technology but how do we combine the right elements to arrive at a single, objective and comparable measure of value?
The first step of the i-vbp® process is to create and validate a value
framework tailored to the areas that encapsulate value for your assets:
i-vbp® shows you both the value of your asset based on current clinical evidence and also the target value that it could achieve with the most robust data package.
The final step is to apply the right monetary thresholds representing the payer’s willingness-to-pay or alternatively benchmark the price of your asset against the price of the current Standard of care treatments.